Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. - Wikidata - awgldk - TriplyDB

Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome.

Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome.

http://www.wikidata.org/entity/Q33258651

about

Urine Proteome Biomarkers in Kidney Diseases. I. Limits, Perspectives, and First Focus on Normal Urine Urine Proteomics in the Era of Mass Spectrometry Biomarkers of systemic lupus erythematosus identified using mass spectrometry-based proteomics: a systematic review LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.Urinary Peptide patterns in native kidneys and kidney allografts.Serum albumin fragmentation in end-stage renal disease patients--a pilot study.Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease Potential urinary biomarkers of disease activity in Crohn's disease.Potential urine proteomics biomarkers for primary nephrotic syndrome.Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria Discovery and initial validation of α 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome.Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases.Proteomic profiling of nephrotic syndrome in serum using magnetic bead based sample fractionation & MALDI-TOF MS.LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis.Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling.Comprehensive human urine standards for comparability and standardization in clinical proteome analysis.Inhibition of the metabolic degradation of filtered albumin is a major determinant of albuminuria Recent advances in biomarker discovery in solid organ transplant by proteomics.Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers.Urine proteomics: the present and future of measuring urinary protein components in disease Serum proteomics for the diagnosis of nephrotic syndrome: is there a ray of hope?Current state of the art for enhancing urine biomarker discovery.Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.Effects of urine composition on epithelial Na+ channel-targeted protease activity.Diagnostic potential for urinary proteomics.Biomarkers of lupus nephritis determined by serial urine proteomics Urine in clinical proteomics.Urine proteomic profiling to identify biomarkers of steroid resistance in pediatric nephrotic syndrome.Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.The novel diagnostic biomarkers for focal segmental glomerulosclerosis.Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?Profiling the proteome in renal transplantation.

P2860

Q26753163-5844925B-B1E4-48F3-9E5A-30205FA05548 Q28069061-FC6927BD-FBFB-44A8-A9D0-2103183D6CE3 Q28071491-60908AAC-23D4-4062-8AA8-1C2FE2314B02 Q28544395-7768E1F8-E06B-4466-BD4D-39CFCA12586B Q30430034-0EBE7D0E-CDF2-4C4E-9301-E4BA3FB03346 Q30434677-71AEE04D-6E99-47BA-8C89-BF53A963D02F Q30437141-07B8AC4B-F5D8-430A-989A-8905DE7E65EF Q30438814-930E92DF-4502-4FD6-BAAA-7D527CB6E1C2 Q33436829-5287DC4A-D7DE-4A16-90BC-74B9D9517F67 Q33471334-5537BFAD-7A8B-482A-B81A-883288D657E6 Q33506511-2247D461-812C-4907-BF59-04628F893329 Q33597457-EEC7456A-D378-467D-9EF6-AE6888F76151 Q33638861-25571179-9F0E-4AF6-82C0-59D1E1CBC6C0 Q33697151-429618D6-F5D5-4D01-8DAA-278E7EF29F9B Q33735287-17EAF57E-155E-40C9-B9B8-EE6A176F89FC Q33904402-40F7CE41-BA9D-4167-8358-70876C2D9EC1 Q33985444-24F0F3CF-B89E-4986-B9CF-FC3BEE1498B2 Q34187912-513DAB79-7AD3-4FFB-BE2D-F929A20E298D Q34259029-D6611CB0-BF7F-45AC-BEB5-35BE1F96BEBF Q34480669-12196B4B-19C0-49C3-A411-65CC37EB680B Q34538751-32869AB4-E509-4C69-80CE-E04E05C2B0A8 Q34664488-CC090DC7-77C9-4E1C-A329-C284E63E1588 Q34725022-9EE0B53B-0F39-486E-87FC-FE2EF5F463AC Q35641683-CE9FDB20-D50C-4B0B-A1DE-4061F855221C Q35764483-54E561BF-C6A0-473E-BABE-D897F86F9EF8 Q35862682-2849EE50-3F70-42E2-8201-361F3919261A Q35929449-B48FCFE4-0733-4B98-84F2-C733ABDF817F Q35993234-6F57B6DE-0B99-4E88-9F49-FE3D62E48239 Q36032361-F971F82C-A476-4C2E-B1AF-761C21DF053B Q36259382-2DB48D0B-7BE9-47D7-97DD-1D19A4802D3A Q36270335-26BD9A70-8701-4837-8C53-903AF618BE2E Q36357542-40F18DC0-4565-41F9-9CD3-CBD93747C7A0 Q36745677-49ECCBC3-A683-443B-99F8-930BE35B30F4 Q37038307-95501F9B-9263-421E-BF03-94D5B7BC7777 Q37230698-19C3084B-1800-4A84-B4A8-77D03284C660 Q37304136-1649953C-CD8B-4B76-8229-5FAD49BF7433 Q37534352-DAB77CCC-7EAC-446A-8A51-65F2811369ED Q37699843-3CBA8FFB-85D0-4E43-BB45-CC37D1983D87 Q37702279-685B6531-CC8D-4206-A589-BA5A90FDEF50 Q37869065-5BFA0F4D-D01A-402E-961E-F577B9324BA4

P2860

Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome.

http://www.wikidata.org/entity/Q33258651

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Repetitive fragmentation produ ...... iated with nephrotic syndrome.

@ast

Repetitive fragmentation produ ...... iated with nephrotic syndrome.

@en

Repetitive fragmentation produ ...... iated with nephrotic syndrome.

@nl

type

label

Repetitive fragmentation produ ...... iated with nephrotic syndrome.

@ast

Repetitive fragmentation produ ...... iated with nephrotic syndrome.

@en

Repetitive fragmentation produ ...... iated with nephrotic syndrome.

@nl

prefLabel

Repetitive fragmentation produ ...... iated with nephrotic syndrome.

@ast

Repetitive fragmentation produ ...... iated with nephrotic syndrome.

@en

Repetitive fragmentation produ ...... iated with nephrotic syndrome.

@nl

P1433

Q33258651-333737BD-378D-4A91-B7A7-D7A7C97195AE

P1476

Q33258651-D9CA03F0-0FEC-4C06-BDFF-33F76E15526F

P2093

Q33258651-27B57445-953B-41CC-95D8-94FD069602A4

Q33258651-349E31C2-A54E-4BC0-AE1F-1F43AD73399C

Q33258651-4A051DBB-95A2-4856-AB2B-1949F393EB59

Q33258651-8159D711-77AC-4F57-8C2F-59F53FA2073D

Q33258651-A250BEED-FB57-4953-A799-9576BB6F95D9

Q33258651-EF30F90C-D126-4B77-96DA-3C8641F6C4A5

P304

Q33258651-4F525C15-4783-4A02-9864-1F908CC77353

P31

Q33258651-6DFED9AA-EEA3-40C7-BF77-33745591AC78

P356

Q33258651-3E64A383-559F-46DA-9B0E-05FF8075E462

P433

Q33258651-7815F7DF-FED3-43C0-85B6-9B3764F6D11C

P478

Q33258651-8BB33CB8-45C6-41CA-9739-4C670E1B68A4

P50

Q33258651-006E13D1-9287-4B52-B90C-158E9A24C994

Q33258651-461F704D-3D9A-499D-A769-FD4409B3B498

Q33258651-922F8296-809F-443C-A0AB-05D85C0A812D

Q33258651-B3F3C673-AAF9-4D96-9E5F-963FA2714BF3

Q33258651-B61D86E5-F9D8-4C32-A706-D094D6F33D7E

P577

Q33258651-7C4DBF84-2564-4CA6-892D-02CBC1A45D90

P698

Q33258651-3AAA1C97-0388-45BC-B4D6-1914CB2F700D

P356

P1433

Journal of the American Society of Nephrology

P1476

Repetitive fragmentation produ ...... ciated with nephrotic syndrome

@en

P2093

Andrea Urbani

http://www.w3.org/2001/XMLSchema#string

Barbara Pavone

http://www.w3.org/2001/XMLSchema#string

Francesco Perfumo

http://www.w3.org/2001/XMLSchema#string

Francesco Scolari

http://www.w3.org/2001/XMLSchema#string

Luca Musante

http://www.w3.org/2001/XMLSchema#string

Piero Del Boccio

http://www.w3.org/2001/XMLSchema#string

P304

3139-3148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2006050486

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio Bruschi

Giovanni Candiano

Gian Marco Ghiggeri

Andrea Petretto

P577

2006-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17005933

http://www.w3.org/2001/XMLSchema#string